DEVELOPMENT OF A TYPOLOGY OF ANTIDEPRESSANT USERS: THE ROLE OF MENTAL HEALTH DISORDERS AND SUBSTANCE USE
Main Article Content
Keywords
Antidepressants, psychotropic medication, mental health, substance use, longitudinal study, profile of use
Abstract
Background / Objectives
Antidepressants constitute one of the most consumed classes of psychotropic medication. This study aims to identify a typology of users based on their individual characteristics, such as presence of a mental disorder and use of other psychotropic medication during the last year .
Methods
Antidepressant use for residents in the epidemiological zone of South- West Montreal aged 15 years and older was documented in 2009, 2011, and 2013. Among the 2433 participants from the initial study, 249 had used antidepressants (10%). A cluster analysis , validated with Chi- square tests and Cramer’s V measure, was conducted with this sample . The longitidinal profile of the clusters was examined using curve clustering .
Results
Based on clinic al variables measured at Time 1 , four types of antidepressant users were identified (p<0,001; 0,58?V?0,81) : depressed users without anxiety (15%), anxio -depressive users with substance dependence and polypharmacy (26%) , depressed users with polypharmacy and being treated by a psychiatrist (31%) and users without mental health disorders (28 %) . Follow -ups two and four years later indicate a higher proportion of participants with symptoms of depression persist ing over time within the cohort of persons having concurrent anxiety and substance dependence .
Conclusions
Results help improve knowledge about the context of antidepressant use in order to plan appropriate interventions . Depressed persons without anxiety appear to receive treatment from general practitioners , while those with comorbid psychotic disorders and depression may require specialized treatment from a psychiatrist . A nxio -depressive users with substance dependence and polypharmacy may require integrated services from different specialized networks in order to counter symptoms related to comorbidity .
References
2. Hanlon JT, Handler SM, Castle NG. Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications. J Am Med Dir Assoc Jun 2010;11(5):320 -4.
3. Raymond C, Morgan S, Caetan o P. Antidepressant utilization in British Columbia f rom 1996 to 2004: increasing prevalence but not incidenc e. Psychiatr Serv 2007;58(1):79 -84.
4. Lesage A, Rhéaume J, Vasiliadis HM. Utilisation de services et consommation de médicaments liées aux problèmes de santé mentale chez les adultes québécois. Enquête sur la santé dans les collectivités canadiennes (cycle 1.2). Québec: Institut de la statistique du Québec; 2008:53.
5. Gouvernement du Québec. Portrait de l’usage des antidépresseurs chez les adultes assurés par le régime public d’assurance médicaments du Québec. Québec: Conseil du médicament;2011.
6. Wainstein L, Victorri -Vigneau C, Sébille V, et al. Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis. Int Clin Psychopharmacol 2011;26:54– 62.
7. Milea D. Usage et mésusage dans la prescription des antidépresseurs : l’apport des bases de données: École doctorale (Épidémiologie), Université Lyon 1;2010.
8. Muskens E, Eveleigh R, Lucassen P, et al. Prescr ibing Antidepressants Appropriately (PANDA): a cluster randomized controlled trial in primary care. BMC Fam Pract 2013;14(6):14 -26.
9. Barre -Détrimont C. Les facteurs influençant la prescription d'antidépresseurs en médecine générale, Thèse de doctorat, Unive rsité de Rouen, Rouen: Faculté de médecine et de pharmacie de Rouen; 2013.
10. Beck C, Patten S, Williams J, et al. Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol 2005;40(10):799 -807.
11. Sanyal C, Asbridge M, Kisely S, et al. The utiliza tion of antidepressants and benzodiazepines among people with major depression in Canada. Can J Psychiatry 2011;56(11):667- 76.
12. Meijer W, Heerdink E, Leufkens H, et al. Incidence and determinants of long -term use of antidepressants. Eur J Clin Pharmacol 2004;60(1):57 -61.
13. Caron J, Fleury MJ, Perreault M, et al. Prevalence of psychological distress and mental disorders, and use of mental health services in the epidemiological catchment area of Montreal South -West. BMC Psychiatry Oct 30 2012;12(1):183.
14. Natio nal Population Health Survey (NPHS). Available at: http://www.hc -sc.gc.ca/fn - an/surveill/nutrition/population/index -eng.php (consulted September 15, 2011).
15. Kessler R, Andrews G, Mroczek D, et al. The World Health Organisation Composite International Diagnostic Interview Short_Form (CIDISF). Int J Methods Psychiatr Res 1998;7:171- 85.
16. Kessler R, Barker P, Colpe L, et al. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003;60(2):184 -9.
17. Cutrona CE, Russell DW. The provisions of social support and adaptation to stress. Advance in Personal Relationships 1987;1:37- 67.
18. Rapkin BD, Luke DA. Cluster analysis in community research: Epi stemology and practice. Am J Community Psychol 1993;21(2):247– 77.
19. Clatworthy J, Buick D, Hankins M, et al. The use and reporting of cluster analysis in health psychology: a review. Br J Health Psychol 2005;10(3):329 -58.
20. Norusis MJ. Chapter 16 - Cluster Anal ysis. SPSS 17.0. Statistical Procedures Companion. Upper Saddle River, N.J.: Prentice Hall; 2008.
21. Patten S, Wang J, Williams J, et al. Descriptive epidemiology of major depression in Canada. Can J Psychiatry 2006;51(2):84 -90.
22. Turpide B, Joseph G. Portrait sociodémographique, socioéconomique et scolaire de la région de Montréal. Québec en forme vis ton énergie. Available at: http://www.centre123go.ca/upload/documents/62A 2B479- 2DA8 -0507 -B71E -33334FA113D1 - portrait_montreal_QEF.pdf (consulté le 12 septembre 2011).
23. Perreault M, Djemaâ -Samia M -T, Fleury M -J, et al. Facteurs associés à l’exposition élevée aux médicaments psychotropes identifiés lors d’une étude épidémiologique montréalaise. Santé Mentale au Québec 2013;38(1):259 -78.
24. Turgeon M. Portrait de l’usage des antidépresseurs chez les adultes assurés par le régime public d’assurance médicaments du Québec. Québec: Conseil du Médicament du Québec; 2011.
25. Olfson M, Marcus S. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009;66(8):848 -56.
26. Furukawa T, Streiner D, Young L, et al. Antidepressants plus benzodiazepines for major depression. In: Art I, ed. Cochrane Database of Systematic Reviews 2001: The Cochrane Collaboration; 2009.
27. Caron J, Liu A. Predictors of p sychological distre ss in the Canadian p opulation: a comparison of low - income and non low -income populations. Community Ment Health J 2011;47(3):318 -30.
28. Caron J, Latimer E, Tousignant M. Predictors of psychological distress in low income populations of Montreal. Can J Public Health 2007;98:35 -44.
29. Azar AR, Chopra MP, Cho LY, et al. Remission in major depression: results from a geriatric primary care population. Int J Geriatr Psychiatry 2010;26(1):48 -55.
30. Mojtabai R, Olfson M. National trends in psychotropic medication polypharma cy in office - based psychiatry. Arch Gen Psychiatry 2010;67(1):26 -36.
31. Zhornitsky S, Potvin S, Moteshafi H, et al. Dose - response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo -controlled monotherapy and add -on trials. Int Clin Psychopharmacol 2010;26(4):183- 92.
32. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol 2006;163:197 -203.
33. Tooth L, Ware R, Bain C, et al. Quality of Reporting of Observational Longitudinal Research. Am J Epidemiol 2005;161(3):280- 8.
34. Nordfjærn T, Bjerkeset O, Bratberg G, et al. Socio - demographic, lifestyle and psychological predictors of benzodiazepine and z -hypnotic use patterns. Nordic J P sychiatry 2013;0:1- 10.